Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Baxter
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Patent: 6,083,523

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 6,083,523
Title: Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products
Abstract:An immunoisolatory vehicle for the implantation into an individual of cells which produce a needed product or provide a needed metabolic function. The vehicle is comprised of a core region containing isolated cells and materials sufficient to maintain the cells, and a permselective, biocompatible, peripheral region free of the isolated cells, which immunoisolates the core yet provides for the delivery of the secreted product or metabolic function to the individual.
Inventor(s): Dionne; Keith E. (Rehoboth, MA), Emerich; Dwaine F. (Providence, RI), Hoffman; Diane (Cambridge, MA), Sanberg; Paul R. (Spring Hill, FL), Christenson; Lisa (New Haven, CT), Hegre; Orion D. (Green Valley, AZ), Scharp; David W. (St. Louis, MO), Lacy; Paul E. (Webster Grove, MO), Aebischer; Patrick (Lutry, CH), Vasconcellos; Alfred V. (Cranston, RI), Lysaght; Michael J. (Greenwich, RI), Gentile; Frank T. (Warwich, RI)
Assignee: Brown University Research Foundation (Providence, RI) Brown University (Providence, RI)
Application Number:09/148,671
Patent Claims:see list of patent claims

Details for Patent 6,083,523

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Nps Pharmaceuticals, Inc. NATPARA parathyroid hormone For Injection 125511 2015-01-23 ⤷  Try it Free 2011-04-25
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
McKinsey
Moodys
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.